2.805EURMkt Cap: 195.03M EURP/E: —Last update: 2026-05-21
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The compa…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap195.03M EUR
Enterprise Value102.66M EUR
Revenue (TTM)5.41M EUR
Gross Profit2.74M EUR
Net Income (TTM)-41.79M EUR
Revenue/Share0.1160 EUR
Last Price2.805 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees137
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINNL0015000HT4
Valuation
P/E (Trailing)—
P/E (Forward)-5.40
PEG—
EV/EBITDA-2.54
EV/Revenue18.96
P/S36.02
P/B2.84
EPS (TTM)-0.90
EPS (Forward)-0.52
52W Range
2.76562% of range2.830
52W High2.830 EUR
52W Low2.765 EUR
Profitability
Gross Margin72.51%
Oper. Margin-494.49%
EBITDA Margin0.00%
Profit Margin-1105.48%
ROE-75.54%
ROA-49.42%
Growth
Revenue Growth176.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.07M EUR
CapEx (TTM)432.00K EUR
FCF Margin-439.37%
FCF Yield-12.20%
Net Debt-54.45M EUR
Net Debt/EBITDA1.35
Balance Sheet
Debt/Equity0.25
Current Ratio6.67
Quick Ratio6.40
Book Value/Sh0.9880 EUR
Cash/Share1.216 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.780 EUR
Target Range8.100 EUR – 11.30 EUR
# Analysts5
Ownership
Shares Out.69.53M
Float43.65M
Insiders28.48%
Institutions23.84%
Technical
SMA 503.080 (-8.9%)
SMA 2004.160 (-32.6%)
Beta0.85
S&P 52W Chg28.31%
Avg Vol (30d)94.38K
Avg Vol (10d)137.18K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—